Variant report
Variant | esv3405919 |
---|---|
Chromosome Location | chr3:34894548-34896696 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs145243401 | chr3:34894565-34894566 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
2 | rs532493778 | chr3:34894569-34894570 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs188089692 | chr3:34894574-34894575 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs571169065 | chr3:34894582-34894583 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs538133496 | chr3:34894639-34894640 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs543577638 | chr3:34894666-34894667 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs138461864 | chr3:34894682-34894683 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs149636877 | chr3:34894707-34894708 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs9837182 | chr3:34894749-34894750 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
10 | rs373093725 | chr3:34894869-34894870 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs377578775 | chr3:34894910-34894911 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs572040339 | chr3:34895006-34895007 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs191382964 | chr3:34895014-34895015 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs144406900 | chr3:34895035-34895036 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs558923980 | chr3:34895045-34895046 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs141430951 | chr3:34895046-34895047 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs531668324 | chr3:34895068-34895069 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs543315333 | chr3:34895159-34895160 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs528036104 | chr3:34895168-34895169 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs531958038 | chr3:34895181-34895182 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs369716635 | chr3:34895226-34895227 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs562889913 | chr3:34895247-34895248 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs199806872 | chr3:34895310-34895311 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs373799703 | chr3:34895313-34895314 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs148770341 | chr3:34895315-34895316 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs71074342 | chr3:34895322-34895323 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs377216261 | chr3:34895327-34895328 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs369675902 | chr3:34895330-34895331 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs372295566 | chr3:34895333-34895334 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs376159225 | chr3:34895336-34895337 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs13096391 | chr3:34895339-34895340 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs75219356 | chr3:34895342-34895343 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs61089342 | chr3:34895345-34895346 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs530066544 | chr3:34895348-34895349 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs200990316 | chr3:34895349-34895350 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs547895463 | chr3:34895353-34895354 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs10635172 | chr3:34895357-34895358 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs572215402 | chr3:34895393-34895394 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs540833870 | chr3:34895444-34895445 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs369329648 | chr3:34895445-34895446 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs9880012 | chr3:34895512-34895513 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs567786881 | chr3:34895531-34895532 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs530258415 | chr3:34895576-34895577 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs561259794 | chr3:34895598-34895599 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs527780589 | chr3:34895643-34895644 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs552765311 | chr3:34895647-34895648 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs570292523 | chr3:34895650-34895651 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs190488875 | chr3:34895725-34895726 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs373288814 | chr3:34895733-34895734 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs556394083 | chr3:34895756-34895757 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Glioblastoma multiforme | 21080181 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Colorectal cancer | 21297112 | CNVD |
Lynch syndrome | 18415027 | CNVD |
Renal cell carcinoma | 18592004 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Urothelial carcinoma | 18382360 | CNVD |
Melanoma | 18172304 | CNVD |
Cervical cancer | 21062161 | CNVD |
Hirschsprung''s Disease | 21712996 | CNVD |
head and neck squamous cell carcinoma | 17671120 | CNVD |
Insulin resistance | 16721378 | CNVD |
Neuroblastoma | 18664255 | CNVD |
Monoclonal gammopathy of undetermined significance | 17077331 | CNVD |
Multiple myeloma | 17077331 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Neuroblastoma | 21484798 | CNVD |
Non-small cell lung cancer | 21044232 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Oral cancer | 19627613 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
Epithelial cancer | 22065749 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Liposarcoma | 21253554 | CNVD |
Basal cell lymphoma | 21115979 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Pancreatic endocrine tumor | 20981439 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 21264507 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Oral cancer | 21386901 | CNVD |
Cutaneous squamous cell carcinomas | 19131950 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Uveal melanoma | 21693616 | CNVD |
Retinoblastoma | 21504564 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Renal cell carcinoma | 21668985 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Lung cancer | 20668451 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Lung cancer | 18438408 | CNVD |
Intellectual disability | 22102821 | CNVD |
Breast cancer | 17603634 | CNVD |
Esophageal cancer | 20955586 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Myofibroblastic sarcoma | 19369631 | CNVD |
Breast cancer | 17133270 | CNVD |
Uveal melanoma | 20484589 | CNVD |
Autism | 22495311 | CNVD |
Melanoma | 20688739 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Cancer | 21183584 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Esophageal squamous carcinoma | 17470683 | CNVD |
Wilms tumour | 17204608 | CNVD |
Biliary cancer | 19435499 | CNVD |
Non-small cell lung cancer | 20864512 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
Kartagener syndrome | 16639409 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Cancer | 20164919 | CNVD |
Breast cancer | 21364760 | CNVD |
Bipolar disorder | 20877625 | CNVD |
Bipolar disorder | 21956041 | CNVD |
Bipolar disorder | 22241247 | CNVD |
Biliary cancer | 18923514 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr3:34885600-34897400 | Weak transcription | ES-I3 Cell Line | embryonic stem cell |
2 | chr3:34886000-34897000 | Weak transcription | Fetal Muscle Leg | muscle |
3 | chr3:34891400-34896200 | Weak transcription | Primary neutrophils fromperipheralblood | blood |
4 | chr3:34893200-34897200 | Weak transcription | Fetal Stomach | stomach |
5 | chr3:34893200-34897400 | Weak transcription | Fetal Brain Male | brain |
6 | chr3:34893200-34897800 | Weak transcription | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
7 | chr3:34893600-34897400 | Weak transcription | Dnd41 | blood |
8 | chr3:34894200-34896600 | Weak transcription | Ganglion Eminence derived primary cultured neurospheres | brain |
9 | chr3:34896200-34897400 | Enhancers | Primary neutrophils fromperipheralblood | blood |
10 | chr3:34896400-34897000 | Enhancers | Cortex derived primary cultured neurospheres | brain |
11 | chr3:34896400-34898200 | Enhancers | H1 BMP4 Derived Mesendoderm Cultured Cells | ES cell derived |
12 | chr3:34896600-34898600 | Enhancers | Ganglion Eminence derived primary cultured neurospheres | brain |